Biomedical Engineering, Healthcare & Life Sciences

The healthcare industry accounts for a full 18 percent of the nation’s gross domestic product (GDP), and Stevens produces key research that develops tools to improve medical outcomes; makes patients more comfortable; and supports the planning and operation of medical facilities.

Coordinated by the interdisciplinary Center for Healthcare Innovation (CHI), Stevens faculty and student researchers make significant scientific contributions to the pharmaceutical, biotechnology and medical device industries, to clinical research organizations and medical centers, and to healthcare policy, delivery and management. Interdisciplinary teams capitalize on innovative developments in biology, chemistry, engineering, computer science, management, pharmaceutical manufacturing and business and leverage new nano- and micro-scale technologies to help translate laboratory innovation to patient care and well-being. We also perform research in a range of key related domains such as tissue engineering, computational drug discovery, biomaterial and biosensor development, and healthcare analytics.

Current Stevens projects include a search for cancer drugs targeting the RAS and ERK signaling pathways; searches for emerging therapies for traumatic lung injury and Parkinson's disease; methods that assist the analysis of ICU data to improve stroke-patient care; and work to improve disease models and research protocols for multiple myeloma, breast and prostate cancers and osteoporosis.